Edition:
United States

People: Novartis AG (NVS)

NVS on New York Consolidated

73.96USD
21 Jun 2018
Change (% chg)

$-0.27 (-0.36%)
Prev Close
$74.23
Open
$74.77
Day's High
$74.80
Day's Low
$73.92
Volume
600,939
Avg. Vol
1,657,122
52-wk High
$94.19
52-wk Low
$73.21

Narasimhan, Vasant 

Dr. Vasant (Vas) Narasimhan, M.D., is Member of the Executive Committee at Novartis Inc. He was Global Head of Drug Development and Chief Medical Officer for Novartis, Member of the Executive Committee of Novartis Inc. from February 1, 2016. Dr. Narasimhan previously was Global Head of Development for Novartis Pharmaceuticals, overseeing the entire general medicines pipeline. He has also served as Global Head of the Sandoz Biopharmaceuticals and Oncology Injectables business unit, Global Head of Development for Novartis Vaccines, North America Region Head for Novartis Vaccines, and United States Country President for Novartis Vaccines and Diagnostics. Before joining Novartis in 2005, he worked at McKinsey & Company. Dr. Narasimhan received his medical degree from Harvard Medical School in the US, a master’s degree in public policy from Harvard’s John F. Kennedy School of Government, and a bachelor’s degree in biological sciences from the University of Chicago. During and after his medical studies, he worked on a range of public health issues in developing countries. He is an elected member of the United States National Academy of Medicine and serves on the board of fellows of Harvard Medical School.

Basic Compensation

Total Annual Compensation, CHF 2,456,700
Restricted Stock Awards, CHF --
Long-Term Incentive Plans, CHF 1,870,010
All Other, CHF 219,165
Fiscal Year Total, CHF 4,545,870

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --